Advertisement
Screener

Taysha Gene Therapies, Inc. (TSHA) Finance Lease, Liability, Current

2.8 / 5 stars · 68/120 Roast Me

Taysha Gene Therapies, Inc. Finance Lease, Liability, Current

Taysha Gene Therapies, Inc. (TSHA) had Finance Lease, Liability, Current of $167.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:FinanceLeaseLiabilityCurrent · last filed 2026-08-11

  • 2026-06-30: Finance Lease, Liability, Current $167.00K.
  • 2026-03-31: Finance Lease, Liability, Current $275.00K.
  • 2025-12-31: Finance Lease, Liability, Current $379.00K.
  • 2025-09-30: Finance Lease, Liability, Current $423.00K.
Period endFinance Lease, Liability, Current
2026-06-30$167.00K
10-Q · filed 2026-08-11
2026-03-31$275.00K
10-Q · filed 2026-05-06
2025-12-31$379.00K
10-K · filed 2026-03-19
2025-09-30$423.00K
10-Q · filed 2025-11-04
2025-06-30$412.00K
10-Q · filed 2025-08-12
2025-03-31$402.00K
10-Q · filed 2025-05-15
2024-12-31$391.00K
10-K · filed 2025-02-26
2024-09-30$381.00K
10-Q · filed 2024-11-13
2024-06-30$371.00K
10-Q · filed 2024-08-12
2024-03-31$362.00K
10-Q · filed 2024-05-14
2023-12-31$354.00K
10-K · filed 2024-03-19
2023-09-30$345.00K
10-Q · filed 2023-11-14
2023-06-30$337.00K
10-Q · filed 2023-08-14
2023-03-31$328.00K
10-Q · filed 2023-05-11
2022-12-31$320.00K
10-K · filed 2023-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunocore Holdings plc (IMCR)$1.613B-90.43
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Vericel Corp (VCEL)United States$2.011B93.97
Vor Biopharma Inc. (VOR)United States$1.091B1.60
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10